Tag: Clinical trials

GRI Bio, a biotechnology company based in La Jolla, California, has shared promising preclinical data on its potential treatment for Idiopathic Pulmonary Fibrosis (IPF). The company's leading drug candidate, GRI-0621, has shown positive results...

Mirum Pharmaceuticals, Inc. recently held an investor call to discuss the interim analysis results from two important studies involving the drug Volixibat. The Volixibat VANTAGE Phase 2b study focused on primary biliary cholangitis (PBC),...

Advancements and Projections in the Cell Therapy Market: Insights, Trends, Opportunities, and Recent DevelopmentsThe cell therapy market is projected to reach a revenue of USD 32.5 billion by 2033, with a compound annual growth...

Moderna's Latest Breakthrough in RSV Vaccine Approval Signals Potential Market GrowthModerna, a well-known biotech company that gained prominence during the development of a successful coronavirus vaccine, has recently received positive news that could mark...

BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with Normal C1-Inhibitor after Beginning ORLADEYO® (berotralstat) TreatmentIn a recent presentation at the European Academy of Allergy and Clinical Immunology (EAACI)...

Pharming Group Provides Update on Ongoing Regulatory Review of Leniolisib for the Treatment of APDS in the European UnionLeiden, the Netherlands, May 30, 2024 - Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam:...